Revolution Medicines
RVMD
RVMD
209 hedge funds and large institutions have $5.18B invested in Revolution Medicines in 2024 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 56 increasing their positions, 65 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
1.16% less ownership
Funds ownership: 98.68% → 97.52% (-1.2%)
14% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 65
Holders
209
Holding in Top 10
14
Calls
$12.2M
Puts
$4.65M
Top Buyers
| 1 | +$93.9M | |
| 2 | +$77.4M | |
| 3 | +$55.2M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$46M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$35.1M |
Top Sellers
| 1 | -$95M | |
| 2 | -$92.7M | |
| 3 | -$76.7M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$31.9M |
| 5 |
JP Morgan Chase
New York
|
-$28.4M |